414 related articles for article (PubMed ID: 19699196)
1. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
3. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARα induction in 3T3-L1 preadipocytes.
Lee SK; Lee JO; Kim JH; Kim N; You GY; Moon JW; Sha J; Kim SJ; Lee YW; Kang HJ; Park SH; Kim HS
Cell Signal; 2012 Dec; 24(12):2329-36. PubMed ID: 22885103
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes.
Li L; Wu L; Wang C; Liu L; Zhao Y
Regul Pept; 2007 Mar; 139(1-3):72-9. PubMed ID: 17109977
[TBL] [Abstract][Full Text] [Related]
7. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.
Lee WJ; Kim M; Park HS; Kim HS; Jeon MJ; Oh KS; Koh EH; Won JC; Kim MS; Oh GT; Yoon M; Lee KU; Park JY
Biochem Biophys Res Commun; 2006 Feb; 340(1):291-5. PubMed ID: 16364253
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors gamma and alpha agonists stimulate cardiac glucose uptake via activation of AMP-activated protein kinase.
Xiao X; Su G; Brown SN; Chen L; Ren J; Zhao P
J Nutr Biochem; 2010 Jul; 21(7):621-6. PubMed ID: 19570670
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
10. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
12. Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase.
Suzuki A; Okamoto S; Lee S; Saito K; Shiuchi T; Minokoshi Y
Mol Cell Biol; 2007 Jun; 27(12):4317-27. PubMed ID: 17420279
[TBL] [Abstract][Full Text] [Related]
13. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
14. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
15. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver.
García-Villafranca J; Guillén A; Castro J
Biochimie; 2008 Mar; 90(3):460-6. PubMed ID: 17997005
[TBL] [Abstract][Full Text] [Related]
16. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase.
Bronner M; Hertz R; Bar-Tana J
Biochem J; 2004 Dec; 384(Pt 2):295-305. PubMed ID: 15312046
[TBL] [Abstract][Full Text] [Related]
17. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
Akki A; Seymour AM
Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
[TBL] [Abstract][Full Text] [Related]
18. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
19. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
Chen BL; Ma YD; Meng RS; Xiong ZJ; Wang HN; Zeng JY; Liu C; Dong YG
Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent.
Bumpus NN; Johnson EF
J Pharmacol Exp Ther; 2011 Dec; 339(3):886-95. PubMed ID: 21896918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]